438 related articles for article (PubMed ID: 27388923)
1. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
[TBL] [Abstract][Full Text] [Related]
2. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
4. Baveno VI Recommendation on Avoidance of Screening Endoscopy in Cirrhotic Patients: Are We There Yet?
Silva MJ; Bernardes C; Pinto J; Loureiro R; Duarte P; Mendes M; Calinas F
GE Port J Gastroenterol; 2017 Mar; 24(2):79-83. PubMed ID: 28848787
[TBL] [Abstract][Full Text] [Related]
5. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
6. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Zhou H; Long J; Hu H; Tian CY; Lin SD
World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
[TBL] [Abstract][Full Text] [Related]
7. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
[TBL] [Abstract][Full Text] [Related]
9. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
10. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
11. Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study).
Garcovich M; Di Stasio E; Zocco MA; Riccardi L; Ainora ME; Annicchiarico BE; Gibiino G; Santopaolo F; Gasbarrini A; Pompili M
Liver Int; 2020 Aug; 40(8):1952-1960. PubMed ID: 32510772
[TBL] [Abstract][Full Text] [Related]
12. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria.
Bai W; Abraldes JG
Curr Opin Gastroenterol; 2022 May; 38(3):206-215. PubMed ID: 35645017
[TBL] [Abstract][Full Text] [Related]
14. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
[TBL] [Abstract][Full Text] [Related]
18. Baveno VI and VII criteria are not suitable for screening for large varices or clinically significant portal hypertension in patients with hepatocellular carcinoma.
Allaire M; Campion B; Demory A; Larrey E; Wagner M; Rudler M; Roux C; Blaise L; Carrie NG; Thabut D
Aliment Pharmacol Ther; 2023 Aug; 58(3):346-356. PubMed ID: 37300315
[TBL] [Abstract][Full Text] [Related]
19. [Noninvasive assessment of the risk of esophageal variceal bleeding from noncirrhotic portal hypertension].
Xu HF; Wang Y; He FL; Fan ZH; Liu H; Yang YP; Jia JD; Liu FQ; Ding HG
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1092-1099. PubMed ID: 36727234
[No Abstract] [Full Text] [Related]
20. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
